Content by Bio X Cell

Scalable, reproducible, and customizable antibodies help scientists keep their research on track.   

Functional antibodies are key experimental tools for targeting the complex tumor microenvironment and developing new immunotherapies.

Researchers turn to preclinical models of metabolic, cardiovascular, and neurological diseases to determine how GLP-1 peptides move beyond diabetes treatment.

In this webinar, Noor Gammoh and Ravi Amaravadi will examine how autophagy influences cancer and its implications for new treatments.

Functional antibodies are highly versatile modulators of health and disease, making them vital tools for disease research and potential therapeutic agents.

Antibody isotypes vary in effector activity and distribution, shaping their roles in immunity and their applications in biomedical research.

In this symposium, an expert panel will discuss how the latest organoid models help researchers discover and develop new drugs. 

New alternative methods and adaptable reagents help researchers reduce, refine, and replace animal testing in drug discovery and development.

Bispecific antibodies have a dual-targeting approach that is proving to be a game-changer in immunotherapeutics research and development.

For immunologists researching autoimmunity, antibodies are both vital tools and potential therapeutic agents.

By including isotype controls in their in vitro and in vivo antibody-based assays, scientists gain confidence in the accuracy of their experimental conclusions.

High performance fluorescently conjugated antibodies designed for flow cytometry and beyond help researchers improve data reliability and streamline experimental design.

The TREM2 receptor may hold the keys to understanding how myeloid cells affect immune responses to neurological disorders and cancer.